JP2021533181A5 - - Google Patents

Info

Publication number
JP2021533181A5
JP2021533181A5 JP2021518993A JP2021518993A JP2021533181A5 JP 2021533181 A5 JP2021533181 A5 JP 2021533181A5 JP 2021518993 A JP2021518993 A JP 2021518993A JP 2021518993 A JP2021518993 A JP 2021518993A JP 2021533181 A5 JP2021533181 A5 JP 2021533181A5
Authority
JP
Japan
Prior art keywords
uchl5
bifunctional molecule
target protein
binding partner
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021518993A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021533181A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/065479 external-priority patent/WO2019238816A1/en
Publication of JP2021533181A publication Critical patent/JP2021533181A/ja
Publication of JP2021533181A5 publication Critical patent/JP2021533181A5/ja
Pending legal-status Critical Current

Links

JP2021518993A 2018-06-13 2019-06-13 UchL5を標的化するための二機能性分子 Pending JP2021533181A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862684268P 2018-06-13 2018-06-13
US62/684,268 2018-06-13
US201962835955P 2019-04-18 2019-04-18
US62/835,955 2019-04-18
PCT/EP2019/065479 WO2019238816A1 (en) 2018-06-13 2019-06-13 Bifunctional molecules for targeting uchl5

Publications (2)

Publication Number Publication Date
JP2021533181A JP2021533181A (ja) 2021-12-02
JP2021533181A5 true JP2021533181A5 (https=) 2022-06-21

Family

ID=67105989

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021518993A Pending JP2021533181A (ja) 2018-06-13 2019-06-13 UchL5を標的化するための二機能性分子

Country Status (7)

Country Link
US (1) US20210283139A1 (https=)
EP (1) EP3807263A1 (https=)
JP (1) JP2021533181A (https=)
KR (1) KR20210020107A (https=)
CN (1) CN112585127A (https=)
CA (1) CA3103205A1 (https=)
WO (1) WO2019238816A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4090371A4 (en) * 2020-01-14 2024-04-03 The Trustees of Columbia University in the City of New York Compositions and methods for targeted protein stabilization by redirecting endogenous deubiquitinases
GB202102494D0 (en) * 2021-02-22 2021-04-07 Amphista Therapeurics Ltd Novel bifunctional molecules for targeted protein degredation
WO2022129925A1 (en) 2020-12-18 2022-06-23 Amphista Therapeutics Limited Novel bifunctional molecules for targeted protein degradation
JP2024513566A (ja) * 2021-04-09 2024-03-26 ザ・ブロード・インスティテュート・インコーポレイテッド 標的基質の選択的修飾のための二官能性分子
KR20240004584A (ko) * 2021-04-29 2024-01-11 노파르티스 아게 탈유비퀴티나아제-표적화 키메라 및 관련된 방법
WO2023242598A1 (en) 2022-06-16 2023-12-21 Amphista Therapeutics Limited Bifunctional molecules for targeted protein degradation
CN119384408A (zh) 2022-06-16 2025-01-28 安菲斯塔治疗有限责任公司 用于靶向蛋白降解的双功能分子
EP4587126A1 (en) 2022-09-13 2025-07-23 Amphista Therapeutics Ltd Compounds for targeted protein degradation
KR20250075705A (ko) 2022-10-07 2025-05-28 화이자 인코포레이티드 Hsd17b13 억제제 및/또는 분해제
EP4634169A1 (en) 2022-12-16 2025-10-22 Pfizer Inc. 3-fluoro-4-hydroxybenzmide-containing inhibitors and/or degraders and uses thereof
WO2025021140A1 (zh) * 2023-07-26 2025-01-30 海南先声再明医药股份有限公司 用于靶蛋白降解类的化合物
WO2025120592A1 (en) 2023-12-07 2025-06-12 Pfizer Inc. Biphenyl and phenylpyridine compounds as inhibitors of kat2a and/or kat2b
GB202319256D0 (en) 2023-12-15 2024-01-31 Amphista Therapeutics Ltd Novel compounds for targeted protein degradation
WO2025221154A1 (en) 2024-04-17 2025-10-23 Captor Therapeutics S.A. Klhdc2 (kelch domain-containing protein 2) ligase ligands

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
EP1169038B9 (en) * 1999-04-15 2013-07-10 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
US7208157B2 (en) 2000-09-08 2007-04-24 California Institute Of Technology Proteolysis targeting chimeric pharmaceutical
EP1896040B1 (en) 2005-06-29 2012-08-01 Threshold Pharmaceuticals, Inc. Phosphoramidate alkylator prodrugs
RU59063U1 (ru) 2006-05-30 2006-12-10 Государственное образовательное учреждение высшего профессионального образования "Ульяновский государственный технический университет" Режущий инструмент с многослойным покрытием
ES2884044T3 (es) 2006-12-26 2021-12-10 Immunogenesis Inc Profármaco alquilante de fosforamidato para el tratamiento del cáncer
GB0913775D0 (en) 2009-08-06 2009-09-16 Medical Res Council Multispecific peptides
WO2012040527A2 (en) * 2010-09-24 2012-03-29 The Regents Of The University Of Michigan Deubiquitinase inhibitors and methods for use of the same
CA2823837A1 (en) 2010-12-07 2012-06-14 Yale University Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
KR102668696B1 (ko) 2012-01-12 2024-05-29 예일 유니버시티 E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법
US20170095457A1 (en) * 2014-05-27 2017-04-06 David Lonergan Compositions and methods of delivery of deubiquitinase inhibitors
US9694084B2 (en) 2014-12-23 2017-07-04 Dana-Farber Cancer Institute, Inc. Methods to induce targeted protein degradation through bifunctional molecules
GB201504314D0 (en) 2015-03-13 2015-04-29 Univ Dundee Small molecules
WO2017024318A1 (en) 2015-08-06 2017-02-09 Dana-Farber Cancer Institute, Inc. Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
WO2017024317A2 (en) 2015-08-06 2017-02-09 Dana-Farber Cancer Institute, Inc. Methods to induce targeted protein degradation through bifunctional molecules
BR112018008918A8 (pt) * 2015-11-02 2019-02-26 Univ Yale compostos de quimera proteólise dirigida e métodos para preparação e uso dos mesmos
GB2554071A (en) * 2016-09-14 2018-03-28 Univ Dundee Small molecules

Similar Documents

Publication Publication Date Title
JP2021533181A5 (https=)
JP2021527137A5 (https=)
JP2018535925A5 (https=)
CN101657454B (zh) 18f-标记的叶酸类
JP2012102106A5 (https=)
US12551583B2 (en) Radiolabeled ligands for targeted PET/SPECT imaging and methods of their use
JP2021513968A5 (https=)
Xu et al. A far-red-emissive AIE active fluorescent probe with large stokes shift for detection of inflammatory bowel disease in vivo
JP5897461B2 (ja) ミエリン塩基性タンパク質のイメージング
TW202302542A (zh) 化合物及放射性標誌化合物
Hübner et al. Functional Hybrid Molecules for the Visualization of Cancer: PESIN‐Homodimers Combined with Multimodal Molecular Imaging Probes for Positron Emission Tomography and Optical Imaging: Suited for Tracking of GRPR‐Positive Malignant Tissue
US11261187B2 (en) Compounds and methods for targeting HSP90
WO2022163807A1 (ja) 光音響イメージング剤
CN114729938B (zh) 发光化合物
KR102228460B1 (ko) Cox2 과발현 질환 진단용 조성물 및 이의 스크리닝 방법
CN120136958A (zh) Fap靶向放射性药物
JP2022526198A (ja) 肺がんの診断方法
Mudd et al. Hybrid PET/CT for noninvasive pharmacokinetic evaluation of dynamic PolyConjugates, a synthetic siRNA delivery system
US7943775B2 (en) Small molecules for imaging protein-protein interactions
CN119325492A (zh) 靶向ca-ix的荧光探针
JP2024528602A (ja) イメージングの為の、標識化された化合物カルシウム感知受容体リガンド、並びにそれらの使用方法
Wang et al. Rational design of pyridinium styryl derivatives as PET tracers for cardiac amyloidosis imaging
JPWO2012121285A1 (ja) 標識前駆体化合物、放射性標識化合物、及びそれらの製造方法
JP7834363B2 (ja) トレーサー化合物およびその調製方法
WO2024257106A1 (en) Polymerization-inducing chimeras targeting homomeric proteins